Correlation Between Connect Biopharma and RAPT Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and RAPT Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and RAPT Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and RAPT Therapeutics, you can compare the effects of market volatilities on Connect Biopharma and RAPT Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of RAPT Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and RAPT Therapeutics.

Diversification Opportunities for Connect Biopharma and RAPT Therapeutics

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Connect and RAPT is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and RAPT Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAPT Therapeutics and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with RAPT Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAPT Therapeutics has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and RAPT Therapeutics go up and down completely randomly.

Pair Corralation between Connect Biopharma and RAPT Therapeutics

Given the investment horizon of 90 days Connect Biopharma Holdings is expected to generate 0.4 times more return on investment than RAPT Therapeutics. However, Connect Biopharma Holdings is 2.47 times less risky than RAPT Therapeutics. It trades about -0.23 of its potential returns per unit of risk. RAPT Therapeutics is currently generating about -0.15 per unit of risk. If you would invest  126.00  in Connect Biopharma Holdings on August 28, 2024 and sell it today you would lose (28.00) from holding Connect Biopharma Holdings or give up 22.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Connect Biopharma Holdings  vs.  RAPT Therapeutics

 Performance 
       Timeline  
Connect Biopharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Connect Biopharma Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Connect Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.
RAPT Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days RAPT Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Connect Biopharma and RAPT Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Connect Biopharma and RAPT Therapeutics

The main advantage of trading using opposite Connect Biopharma and RAPT Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, RAPT Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAPT Therapeutics will offset losses from the drop in RAPT Therapeutics' long position.
The idea behind Connect Biopharma Holdings and RAPT Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like